Surgical Versus Percutaneous Femoral Access for Delivery of Large-Bore Cardiovascular Devices (from the PARTNER Trial)

James M. McCabe, Pei Hsiu Huang, David J. Cohen, Eugene H. Blackstone, Frederick G P Welt, Michael J. Davidson, Tsuyoshi Kaneko, Marvin H. Eng, Keith B. Allen, Ke Xu, Ashley M. Lowry, Yang Lei, Jeevanantham Rajeswaran, David L. Brown, Michael J. Mack, John G. Webb, Craig R. Smith, Martin B. Leon, Andrew C. Eisenhauer

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

It is unclear if surgical exposure confers a risk advantage compared with a percutaneous approach for patients undergoing endovascular procedures requiring large-bore femoral artery access. From the randomized controlled Placement of Aortic Transcatheter Valve trials A and B and the continued access registries, a total of 1,416 patients received transfemoral transcatheter aortic valve replacement, of which 857 underwent surgical, and 559 underwent percutaneous access. Thirty-day rates of major vascular complications and quality of life scores were assessed. Propensity matching was used to adjust for unmeasured confounders. Overall, there were 116 major vascular complications (8.2%). Complication rates decreased dramatically during the study period. In unadjusted analysis, major vascular complications were significantly less common in the percutaneous access group (35 [6.3%] vs 81 [9.5%] p = 0.032). However, among 292 propensity-matched pairs, there was no difference in major vascular complications (22 [7.5%] vs 28 [9.6%], p = 0.37). Percutaneous access was associated with fewer total in-hospital vascular complications (46 [16%] vs 66 [23%], p = 0.036), shorter median procedural duration (97 interquartile range [IQR 68 to 166] vs 121 [IQR 78 to 194] minutes, p

Original languageEnglish (US)
JournalAmerican Journal of Cardiology
DOIs
StateAccepted/In press - Aug 19 2015

Fingerprint

Thigh
Blood Vessels
Equipment and Supplies
Endovascular Procedures
Femoral Artery
Aortic Valve
Registries
Quality of Life

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

McCabe, J. M., Huang, P. H., Cohen, D. J., Blackstone, E. H., Welt, F. G. P., Davidson, M. J., ... Eisenhauer, A. C. (Accepted/In press). Surgical Versus Percutaneous Femoral Access for Delivery of Large-Bore Cardiovascular Devices (from the PARTNER Trial). American Journal of Cardiology. https://doi.org/10.1016/j.amjcard.2016.02.041

Surgical Versus Percutaneous Femoral Access for Delivery of Large-Bore Cardiovascular Devices (from the PARTNER Trial). / McCabe, James M.; Huang, Pei Hsiu; Cohen, David J.; Blackstone, Eugene H.; Welt, Frederick G P; Davidson, Michael J.; Kaneko, Tsuyoshi; Eng, Marvin H.; Allen, Keith B.; Xu, Ke; Lowry, Ashley M.; Lei, Yang; Rajeswaran, Jeevanantham; Brown, David L.; Mack, Michael J.; Webb, John G.; Smith, Craig R.; Leon, Martin B.; Eisenhauer, Andrew C.

In: American Journal of Cardiology, 19.08.2015.

Research output: Contribution to journalArticle

McCabe, JM, Huang, PH, Cohen, DJ, Blackstone, EH, Welt, FGP, Davidson, MJ, Kaneko, T, Eng, MH, Allen, KB, Xu, K, Lowry, AM, Lei, Y, Rajeswaran, J, Brown, DL, Mack, MJ, Webb, JG, Smith, CR, Leon, MB & Eisenhauer, AC 2015, 'Surgical Versus Percutaneous Femoral Access for Delivery of Large-Bore Cardiovascular Devices (from the PARTNER Trial)', American Journal of Cardiology. https://doi.org/10.1016/j.amjcard.2016.02.041
McCabe, James M. ; Huang, Pei Hsiu ; Cohen, David J. ; Blackstone, Eugene H. ; Welt, Frederick G P ; Davidson, Michael J. ; Kaneko, Tsuyoshi ; Eng, Marvin H. ; Allen, Keith B. ; Xu, Ke ; Lowry, Ashley M. ; Lei, Yang ; Rajeswaran, Jeevanantham ; Brown, David L. ; Mack, Michael J. ; Webb, John G. ; Smith, Craig R. ; Leon, Martin B. ; Eisenhauer, Andrew C. / Surgical Versus Percutaneous Femoral Access for Delivery of Large-Bore Cardiovascular Devices (from the PARTNER Trial). In: American Journal of Cardiology. 2015.
@article{9edfd68ffbfe49b9a33aa841251fa9e5,
title = "Surgical Versus Percutaneous Femoral Access for Delivery of Large-Bore Cardiovascular Devices (from the PARTNER Trial)",
abstract = "It is unclear if surgical exposure confers a risk advantage compared with a percutaneous approach for patients undergoing endovascular procedures requiring large-bore femoral artery access. From the randomized controlled Placement of Aortic Transcatheter Valve trials A and B and the continued access registries, a total of 1,416 patients received transfemoral transcatheter aortic valve replacement, of which 857 underwent surgical, and 559 underwent percutaneous access. Thirty-day rates of major vascular complications and quality of life scores were assessed. Propensity matching was used to adjust for unmeasured confounders. Overall, there were 116 major vascular complications (8.2{\%}). Complication rates decreased dramatically during the study period. In unadjusted analysis, major vascular complications were significantly less common in the percutaneous access group (35 [6.3{\%}] vs 81 [9.5{\%}] p = 0.032). However, among 292 propensity-matched pairs, there was no difference in major vascular complications (22 [7.5{\%}] vs 28 [9.6{\%}], p = 0.37). Percutaneous access was associated with fewer total in-hospital vascular complications (46 [16{\%}] vs 66 [23{\%}], p = 0.036), shorter median procedural duration (97 interquartile range [IQR 68 to 166] vs 121 [IQR 78 to 194] minutes, p",
author = "McCabe, {James M.} and Huang, {Pei Hsiu} and Cohen, {David J.} and Blackstone, {Eugene H.} and Welt, {Frederick G P} and Davidson, {Michael J.} and Tsuyoshi Kaneko and Eng, {Marvin H.} and Allen, {Keith B.} and Ke Xu and Lowry, {Ashley M.} and Yang Lei and Jeevanantham Rajeswaran and Brown, {David L.} and Mack, {Michael J.} and Webb, {John G.} and Smith, {Craig R.} and Leon, {Martin B.} and Eisenhauer, {Andrew C.}",
year = "2015",
month = "8",
day = "19",
doi = "10.1016/j.amjcard.2016.02.041",
language = "English (US)",
journal = "American Journal of Cardiology",
issn = "0002-9149",
publisher = "Elsevier Inc.",

}

TY - JOUR

T1 - Surgical Versus Percutaneous Femoral Access for Delivery of Large-Bore Cardiovascular Devices (from the PARTNER Trial)

AU - McCabe, James M.

AU - Huang, Pei Hsiu

AU - Cohen, David J.

AU - Blackstone, Eugene H.

AU - Welt, Frederick G P

AU - Davidson, Michael J.

AU - Kaneko, Tsuyoshi

AU - Eng, Marvin H.

AU - Allen, Keith B.

AU - Xu, Ke

AU - Lowry, Ashley M.

AU - Lei, Yang

AU - Rajeswaran, Jeevanantham

AU - Brown, David L.

AU - Mack, Michael J.

AU - Webb, John G.

AU - Smith, Craig R.

AU - Leon, Martin B.

AU - Eisenhauer, Andrew C.

PY - 2015/8/19

Y1 - 2015/8/19

N2 - It is unclear if surgical exposure confers a risk advantage compared with a percutaneous approach for patients undergoing endovascular procedures requiring large-bore femoral artery access. From the randomized controlled Placement of Aortic Transcatheter Valve trials A and B and the continued access registries, a total of 1,416 patients received transfemoral transcatheter aortic valve replacement, of which 857 underwent surgical, and 559 underwent percutaneous access. Thirty-day rates of major vascular complications and quality of life scores were assessed. Propensity matching was used to adjust for unmeasured confounders. Overall, there were 116 major vascular complications (8.2%). Complication rates decreased dramatically during the study period. In unadjusted analysis, major vascular complications were significantly less common in the percutaneous access group (35 [6.3%] vs 81 [9.5%] p = 0.032). However, among 292 propensity-matched pairs, there was no difference in major vascular complications (22 [7.5%] vs 28 [9.6%], p = 0.37). Percutaneous access was associated with fewer total in-hospital vascular complications (46 [16%] vs 66 [23%], p = 0.036), shorter median procedural duration (97 interquartile range [IQR 68 to 166] vs 121 [IQR 78 to 194] minutes, p

AB - It is unclear if surgical exposure confers a risk advantage compared with a percutaneous approach for patients undergoing endovascular procedures requiring large-bore femoral artery access. From the randomized controlled Placement of Aortic Transcatheter Valve trials A and B and the continued access registries, a total of 1,416 patients received transfemoral transcatheter aortic valve replacement, of which 857 underwent surgical, and 559 underwent percutaneous access. Thirty-day rates of major vascular complications and quality of life scores were assessed. Propensity matching was used to adjust for unmeasured confounders. Overall, there were 116 major vascular complications (8.2%). Complication rates decreased dramatically during the study period. In unadjusted analysis, major vascular complications were significantly less common in the percutaneous access group (35 [6.3%] vs 81 [9.5%] p = 0.032). However, among 292 propensity-matched pairs, there was no difference in major vascular complications (22 [7.5%] vs 28 [9.6%], p = 0.37). Percutaneous access was associated with fewer total in-hospital vascular complications (46 [16%] vs 66 [23%], p = 0.036), shorter median procedural duration (97 interquartile range [IQR 68 to 166] vs 121 [IQR 78 to 194] minutes, p

UR - http://www.scopus.com/inward/record.url?scp=84962304141&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84962304141&partnerID=8YFLogxK

U2 - 10.1016/j.amjcard.2016.02.041

DO - 10.1016/j.amjcard.2016.02.041

M3 - Article

JO - American Journal of Cardiology

JF - American Journal of Cardiology

SN - 0002-9149

ER -